| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPM4 SPNS1 TMEM165 PIEZO1 BAK1 TIMM23 MCL1 SLC12A8 PKDREJ RYR3 SLC35D1 SLC2A10 SLC41A2 SLC35A4 SLC5A6 PKD1 SCN9A ABCD4 KCNQ3 SLC25A53 SLC49A3 SLC25A29 ABCD2 SEC61A1 TAP1 SLC25A17 SLC12A6 CACNA1C TIMM23B SLC19A2 PKD2L1 ABCB6 MFSD4A ABCC9 PKD1L3 SLCO6A1 SLC40A1 P2RX5 PRF1 SLC28A2 SLC7A10 MFSD5 DISP1 MFSD3 | 2.14e-11 | 1180 | 242 | 44 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | TRPM4 SPNS1 TMEM165 PIEZO1 BAK1 TIMM23 MCL1 SLC12A8 PKDREJ RYR3 SLC35D1 SLC2A10 SLC41A2 SLC35A4 SLC5A6 PKD1 SCN9A ABCD4 KCNQ3 SLC25A53 SLC49A3 SLC25A29 ABCD2 SEC61A1 TAP1 SLC25A17 SLC12A6 CACNA1C ESYT1 TIMM23B SLC19A2 PKD2L1 ABCB6 MFSD4A ABCC9 PKD1L3 SLCO6A1 SLC40A1 P2RX5 PRF1 SLC28A2 LRP2 SLC7A10 MFSD5 DISP1 MFSD3 | 3.05e-11 | 1289 | 242 | 46 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPM4 TMEM165 SLC12A8 PKDREJ RYR3 SLC41A2 SLC5A6 PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCC9 PKD1L3 SLC40A1 SLC28A2 | 1.61e-05 | 465 | 242 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPM4 TMEM165 PIEZO1 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCC9 PKD1L3 SLC40A1 P2RX5 SLC28A2 | 6.31e-05 | 664 | 242 | 21 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | TRPM4 TMEM165 PKDREJ RYR3 PKD1 SEC61A1 CACNA1C PKD2L1 PKD1L3 | 9.64e-05 | 151 | 242 | 9 | GO:0015085 |
| GeneOntologyMolecularFunction | sour taste receptor activity | 1.46e-04 | 2 | 242 | 2 | GO:0033040 | |
| GeneOntologyMolecularFunction | protein transporter activity | 1.48e-04 | 42 | 242 | 5 | GO:0140318 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.79e-04 | 129 | 242 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.29e-04 | 46 | 242 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | channel activity | TRPM4 PIEZO1 BAK1 MCL1 PKDREJ RYR3 PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCC9 PKD1L3 P2RX5 PRF1 | 2.42e-04 | 525 | 242 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPM4 TMEM165 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCC9 PKD1L3 SLC40A1 SLC28A2 | 2.44e-04 | 627 | 242 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPM4 PIEZO1 BAK1 MCL1 PKDREJ RYR3 PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCC9 PKD1L3 P2RX5 PRF1 | 2.48e-04 | 526 | 242 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 2.58e-04 | 172 | 242 | 9 | GO:0044325 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM4 PIEZO1 PKDREJ RYR3 PKD1 SCN9A KCNQ3 SEC61A1 CACNA1C PKD2L1 ABCC9 PKD1L3 P2RX5 | 3.01e-04 | 343 | 242 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.10e-04 | 49 | 242 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 3.43e-04 | 28 | 242 | 4 | GO:0008320 | |
| GeneOntologyMolecularFunction | carbohydrate binding | CALR3 MAN2A2 HK2 HK3 GANC PFKL FREM1 PTX3 PKD1 MGAM VTN PKD1L3 | 4.24e-04 | 310 | 242 | 12 | GO:0030246 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPM4 TMEM165 PIEZO1 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCC9 PKD1L3 SLC40A1 P2RX5 SLC28A2 | 6.92e-04 | 793 | 242 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 7.33e-04 | 34 | 242 | 4 | GO:0022884 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 7.37e-04 | 59 | 242 | 5 | GO:0015932 | |
| GeneOntologyMolecularFunction | calcium ion binding | TRPM4 CALR3 PKDREJ F7 RYR3 PLA2G4A ANXA9 ESYT1 EFCAB2 PKD2L1 ADAMTS13 RET PKD1L3 MEGF8 PRF1 TLL2 LPL SLIT1 LRP2 ADGRE5 | 8.37e-04 | 749 | 242 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 9.14e-04 | 36 | 242 | 4 | GO:0090482 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM4 TMEM165 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCC9 PKD1L3 SLC40A1 SLC28A2 MFSD5 | 9.68e-04 | 758 | 242 | 20 | GO:0015318 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.25e-03 | 18 | 242 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | glucokinase activity | 1.43e-03 | 5 | 242 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 1.43e-03 | 5 | 242 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.43e-03 | 5 | 242 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | hexokinase activity | 1.43e-03 | 5 | 242 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 1.43e-03 | 5 | 242 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.90e-03 | 144 | 242 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 1.99e-03 | 21 | 242 | 3 | GO:0019200 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | TMEM165 SLC12A8 SLC35D1 SLC2A10 SLC5A6 ABCD4 ABCD2 TAP1 SLC25A17 SLC12A6 ABCB6 ABCC9 SLCO6A1 SLC28A2 | 2.14e-03 | 477 | 242 | 14 | GO:0022804 |
| GeneOntologyBiologicalProcess | mesenchyme migration | 8.71e-08 | 5 | 239 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 2.61e-05 | 75 | 239 | 7 | GO:0050982 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | LAMA1 SLC2A10 ADAMTS9 PTX3 ANTXR1 COL14A1 SCARA3 COL4A2 COL12A1 VTN WASHC1 SEMA5A ADAMTS13 TGFB1 TLL2 | 3.66e-05 | 377 | 239 | 15 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | LAMA1 SLC2A10 ADAMTS9 PTX3 ANTXR1 COL14A1 SCARA3 COL4A2 COL12A1 VTN WASHC1 SEMA5A ADAMTS13 TGFB1 TLL2 | 3.77e-05 | 378 | 239 | 15 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | LAMA1 SLC2A10 ADAMTS9 PTX3 ANTXR1 COL14A1 SCARA3 COL4A2 COL12A1 VTN WASHC1 SEMA5A ADAMTS13 TGFB1 TLL2 | 3.89e-05 | 379 | 239 | 15 | GO:0045229 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPM4 TMEM165 PIEZO1 BAK1 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 APLNR PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCB6 ABCC9 PKD1L3 SLC40A1 EDN3 TGFB1 P2RX5 GNB5 | 3.91e-05 | 942 | 239 | 26 | GO:0098655 |
| GeneOntologyBiologicalProcess | metal ion transport | TRPM4 TMEM165 BAK1 SLC12A8 PKDREJ RYR3 SLC41A2 SLC5A6 APLNR PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C WFS1 PKD2L1 ABCB6 ABCC9 PKD1L3 SLC40A1 EDN3 TGFB1 SPTBN4 P2RX5 GNB5 LRP2 | 4.02e-05 | 1000 | 239 | 27 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | TRPM4 TMEM165 BAK1 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 APLNR PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCB6 ABCC9 PKD1L3 SLC40A1 EDN3 TGFB1 P2RX5 GNB5 | 7.37e-05 | 922 | 239 | 25 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | TRPM4 TMEM165 PIEZO1 BAK1 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 APLNR PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C WFS1 PKD2L1 ABCB6 ABCC9 PKD1L3 SLC40A1 EDN3 TGFB1 SPTBN4 P2RX5 GNB5 LRP2 | 7.76e-05 | 1157 | 239 | 29 | GO:0006812 |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 1.06e-04 | 65 | 239 | 6 | GO:0072132 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | CYBB HK2 PIEZO1 ACTA1 BAK1 ATAT1 PKDREJ F7 MEN1 PTPRK PTPRQ PKD1 SCN9A KCNQ3 SCARA3 SLC12A6 CACNA1C FBXL17 PKD2L1 ABCC9 SEMA5A PKD1L3 RHO TGFB1 SCAP P2RX5 GNB5 LRP2 LRRN4 IL1R1 MAP2K7 EPHA4 | 1.07e-04 | 1361 | 239 | 32 | GO:0009628 |
| GeneOntologyBiologicalProcess | axonogenesis | MYCBP2 ACTBL2 LAMA1 LGR4 ADARB1 ADCY1 DSCAML1 SPG21 ACTL9 SEMA4F SEMA5A RET EDN3 SPTBN4 MEGF8 SLIT1 LRP2 EPHA4 | 1.14e-04 | 566 | 239 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon guidance | MYCBP2 LAMA1 LGR4 DSCAML1 SEMA4F SEMA5A RET EDN3 MEGF8 SLIT1 LRP2 EPHA4 | 1.31e-04 | 285 | 239 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of sour taste | 1.34e-04 | 2 | 239 | 2 | GO:0001581 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | MYCBP2 LAMA1 LGR4 DSCAML1 SEMA4F SEMA5A RET EDN3 MEGF8 SLIT1 LRP2 EPHA4 | 1.35e-04 | 286 | 239 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | PIEZO1 ACTA1 ATAT1 PKDREJ PTPRQ PKD1 SCN9A KCNQ3 PKD2L1 PKD1L3 TGFB1 | 1.53e-04 | 247 | 239 | 11 | GO:0009612 |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 1.84e-04 | 25 | 239 | 4 | GO:0046835 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.93e-04 | 173 | 239 | 9 | GO:0009581 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | TRPM4 TMEM165 BAK1 PKDREJ RYR3 APLNR PKD1 SEC61A1 CACNA1C PKD2L1 PKD1L3 TGFB1 P2RX5 GNB5 | 2.06e-04 | 392 | 239 | 14 | GO:0070588 |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 2.11e-04 | 175 | 239 | 9 | GO:0009582 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CYBB TRPM4 TMEM165 PIEZO1 BAK1 SLC12A8 PKDREJ RYR3 SLC2A10 SLC41A2 SLC5A6 APLNR PKD1 SCN9A KCNQ3 SEC61A1 SLC12A6 CACNA1C PKD2L1 ABCB6 ABCC9 PKD1L3 SLC40A1 EDN3 TGFB1 P2RX5 GNB5 | 2.42e-04 | 1115 | 239 | 27 | GO:0034220 |
| GeneOntologyCellularComponent | vesicle membrane | CYBB MON2 RAB9B TMEM165 COPE IRF7 ITGA2B ITGAL CD163 SPG21 WASH6P VPS52 NBEAL2 PKD1 RAB7A ANTXR1 ANXA9 SEC61A1 TAP1 MGAM ANKFY1 WFS1 WASHC1 ABCB6 RET RHO SCAP APH1A SLC28A2 LRP2 ADGRE5 EPHA4 | 7.58e-05 | 1325 | 244 | 32 | GO:0012506 |
| GeneOntologyCellularComponent | filopodium | 9.98e-05 | 123 | 244 | 8 | GO:0030175 | |
| GeneOntologyCellularComponent | cell surface | ITGA2B ITGAD ITGAL DSCAML1 CD163 NOD2 PTPRK ADAMTS9 CD163L1 BTN1A1 PKD1 ANTXR1 KCNQ3 ANXA9 ADGRA3 CACNA1C PKD2L1 ADAMTS13 PKD1L3 TGFB1 LPL LRP2 ADGRE5 ROS1 LPAR2 IL1R1 IGSF21 EPHA4 | 1.08e-04 | 1111 | 244 | 28 | GO:0009986 |
| GeneOntologyCellularComponent | migrasome | 1.25e-04 | 9 | 244 | 3 | GO:0140494 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CYBB MON2 RAB9B TMEM165 COPE IRF7 ITGA2B ITGAL CD163 SPG21 WASH6P VPS52 NBEAL2 PKD1 RAB7A ANTXR1 SEC61A1 TAP1 MGAM ANKFY1 WFS1 WASHC1 ABCB6 RET RHO SCAP APH1A LRP2 ADGRE5 EPHA4 | 3.10e-04 | 1307 | 244 | 30 | GO:0030659 |
| GeneOntologyCellularComponent | anchoring collagen complex | 4.04e-04 | 3 | 244 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | cation channel complex | TRPM4 RYR3 PKD1 SCN9A KCNQ3 CACNA1C PKD2L1 ABCC9 PKD1L3 SLCO6A1 | 4.61e-04 | 235 | 244 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.23e-04 | 59 | 244 | 5 | GO:0098636 | |
| Domain | ACTINS_1 | 1.22e-10 | 8 | 242 | 6 | PS00406 | |
| Domain | Actin_CS | 3.20e-08 | 16 | 242 | 6 | IPR004001 | |
| Domain | ACTINS_2 | 4.88e-08 | 17 | 242 | 6 | PS00432 | |
| Domain | Actin | 1.13e-07 | 31 | 242 | 7 | IPR004000 | |
| Domain | Actin | 1.13e-07 | 31 | 242 | 7 | PF00022 | |
| Domain | ACTIN | 1.13e-07 | 31 | 242 | 7 | SM00268 | |
| Domain | MFS_dom | SPNS1 UNC93A SLC2A10 SLC49A3 MFSD11 SLC19A2 MFSD4A SLCO6A1 SLC40A1 MFSD5 MFSD3 | 1.39e-06 | 134 | 242 | 11 | IPR020846 |
| Domain | Actin/actin-like_CS | 2.62e-06 | 18 | 242 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 3.51e-06 | 19 | 242 | 5 | PS01132 | |
| Domain | ConA-like_dom | CALR3 LAMA1 RYR3 PTPRK PTX3 NBEAL2 BTN1A1 COL14A1 HERC1 COL12A1 RSPRY1 SLIT1 RFPL2 | 5.92e-06 | 219 | 242 | 13 | IPR013320 |
| Domain | VWA | 7.59e-06 | 56 | 242 | 7 | PF00092 | |
| Domain | PKD_channel | 8.45e-06 | 11 | 242 | 4 | PF08016 | |
| Domain | PKD1_2_channel | 8.45e-06 | 11 | 242 | 4 | IPR013122 | |
| Domain | PC1 | 8.51e-06 | 4 | 242 | 3 | IPR000434 | |
| Domain | ABC_TM1F | 2.70e-05 | 28 | 242 | 5 | PS50929 | |
| Domain | ABC1_TM_dom | 2.70e-05 | 28 | 242 | 5 | IPR011527 | |
| Domain | - | KATNB1 EML2 BIRC6 NBEAL2 POC1B WDR90 HERC1 SEMA4F SEMA5A WDFY4 EML3 SCAP DCAF10 ARHGEF10 GNB5 | 3.13e-05 | 333 | 242 | 15 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | KATNB1 EML2 BIRC6 NBEAL2 POC1B WDR90 HERC1 SEMA4F SEMA5A WDFY4 EML3 SCAP DCAF10 ARHGEF10 GNB5 | 3.35e-05 | 335 | 242 | 15 | IPR015943 |
| Domain | GPS | 7.17e-05 | 34 | 242 | 5 | SM00303 | |
| Domain | LH2 | 7.29e-05 | 18 | 242 | 4 | SM00308 | |
| Domain | VWFA | 9.36e-05 | 82 | 242 | 7 | PS50234 | |
| Domain | GPS | 1.09e-04 | 37 | 242 | 5 | IPR000203 | |
| Domain | VWA | 1.09e-04 | 84 | 242 | 7 | SM00327 | |
| Domain | - | 1.38e-04 | 21 | 242 | 4 | 2.60.60.20 | |
| Domain | PLAT | 1.38e-04 | 21 | 242 | 4 | PF01477 | |
| Domain | PLAT/LH2_dom | 1.38e-04 | 21 | 242 | 4 | IPR001024 | |
| Domain | PLAT | 1.38e-04 | 21 | 242 | 4 | PS50095 | |
| Domain | WD40_repeat_dom | KNTC1 KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 ARHGEF10 GNB5 | 1.41e-04 | 297 | 242 | 13 | IPR017986 |
| Domain | ABC_transporter_CS | 2.02e-04 | 42 | 242 | 5 | IPR017871 | |
| Domain | VWF_A | 3.04e-04 | 99 | 242 | 7 | IPR002035 | |
| Domain | Integrin_alpha | 3.28e-04 | 11 | 242 | 3 | PF00357 | |
| Domain | ABC_tran | 3.81e-04 | 48 | 242 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.81e-04 | 48 | 242 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.20e-04 | 49 | 242 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 4.62e-04 | 50 | 242 | 5 | IPR003439 | |
| Domain | Ion_channel_UNC-93 | 4.97e-04 | 3 | 242 | 2 | IPR010291 | |
| Domain | UNC-93 | 4.97e-04 | 3 | 242 | 2 | PF05978 | |
| Domain | WD40 | KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 GNB5 | 5.86e-04 | 259 | 242 | 11 | PF00400 |
| Domain | AAA | 5.87e-04 | 144 | 242 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 5.87e-04 | 144 | 242 | 8 | IPR003593 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.04e-04 | 14 | 242 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.04e-04 | 14 | 242 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.04e-04 | 14 | 242 | 3 | IPR013602 | |
| Domain | DHC_N2 | 7.04e-04 | 14 | 242 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 7.04e-04 | 14 | 242 | 3 | IPR011704 | |
| Domain | MT | 7.04e-04 | 14 | 242 | 3 | PF12777 | |
| Domain | AAA_8 | 7.04e-04 | 14 | 242 | 3 | PF12780 | |
| Domain | AAA_5 | 7.04e-04 | 14 | 242 | 3 | PF07728 | |
| Domain | WD40 | KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 GNB5 | 7.77e-04 | 268 | 242 | 11 | SM00320 |
| Domain | DHC_fam | 8.71e-04 | 15 | 242 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 8.71e-04 | 15 | 242 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.71e-04 | 15 | 242 | 3 | IPR004273 | |
| Domain | WD40_repeat | KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 GNB5 | 8.77e-04 | 272 | 242 | 11 | IPR001680 |
| Domain | ABC_membrane_2 | 9.86e-04 | 4 | 242 | 2 | PF06472 | |
| Domain | REJ | 9.86e-04 | 4 | 242 | 2 | PS51111 | |
| Domain | REJ_dom | 9.86e-04 | 4 | 242 | 2 | IPR014010 | |
| Domain | WD_REPEATS_1 | KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 GNB5 | 1.05e-03 | 278 | 242 | 11 | PS00678 |
| Domain | GPS | 1.05e-03 | 35 | 242 | 4 | PF01825 | |
| Domain | Integrin_alpha_C_CS | 1.06e-03 | 16 | 242 | 3 | IPR018184 | |
| Domain | WD_REPEATS_2 | KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 GNB5 | 1.08e-03 | 279 | 242 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 GNB5 | 1.08e-03 | 279 | 242 | 11 | PS50294 |
| Domain | GPS | 1.17e-03 | 36 | 242 | 4 | PS50221 | |
| Domain | fn3 | 1.26e-03 | 162 | 242 | 8 | PF00041 | |
| Domain | Gal_mutarotase_SF_dom | 1.28e-03 | 17 | 242 | 3 | IPR011013 | |
| Domain | WD40_repeat_CS | 1.37e-03 | 164 | 242 | 8 | IPR019775 | |
| Domain | Galactose-bd-like | 1.40e-03 | 94 | 242 | 6 | IPR008979 | |
| Domain | Integrin_alpha-2 | 1.52e-03 | 18 | 242 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 1.52e-03 | 18 | 242 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 1.52e-03 | 18 | 242 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.52e-03 | 18 | 242 | 3 | IPR000413 | |
| Domain | Hexokinase_2 | 1.63e-03 | 5 | 242 | 2 | PF03727 | |
| Domain | Hexokinase_BS | 1.63e-03 | 5 | 242 | 2 | IPR019807 | |
| Domain | Hexokinase_C | 1.63e-03 | 5 | 242 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 1.63e-03 | 5 | 242 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 1.63e-03 | 5 | 242 | 2 | PF00349 | |
| Domain | PKD_2 | 1.63e-03 | 5 | 242 | 2 | IPR003915 | |
| Domain | HEXOKINASE_2 | 1.63e-03 | 5 | 242 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 1.63e-03 | 5 | 242 | 2 | PS00378 | |
| Domain | EGF_Ca-bd_CS | 1.65e-03 | 97 | 242 | 6 | IPR018097 | |
| Domain | Int_alpha | 1.79e-03 | 19 | 242 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.79e-03 | 19 | 242 | 3 | IPR013519 | |
| Domain | EGF_CA | 1.83e-03 | 99 | 242 | 6 | PS01187 | |
| Domain | Glyco_hydro_31_AS | 2.42e-03 | 6 | 242 | 2 | IPR030458 | |
| Domain | HELP | 2.42e-03 | 6 | 242 | 2 | PF03451 | |
| Domain | Hexokinase | 2.42e-03 | 6 | 242 | 2 | IPR001312 | |
| Domain | PKD/REJ-like | 2.42e-03 | 6 | 242 | 2 | IPR002859 | |
| Domain | REJ | 2.42e-03 | 6 | 242 | 2 | PF02010 | |
| Domain | HELP | 2.42e-03 | 6 | 242 | 2 | IPR005108 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.58e-03 | 106 | 242 | 6 | IPR000152 | |
| Domain | - | 2.73e-03 | 74 | 242 | 5 | 3.40.50.410 | |
| Domain | FG_GAP | 2.76e-03 | 22 | 242 | 3 | PS51470 | |
| Domain | AA-permease/SLC12A_dom | 2.76e-03 | 22 | 242 | 3 | IPR004841 | |
| Domain | AA_permease | 2.76e-03 | 22 | 242 | 3 | PF00324 | |
| Domain | MFS | 2.83e-03 | 108 | 242 | 6 | PS50850 | |
| Domain | FN3 | 2.90e-03 | 185 | 242 | 8 | SM00060 | |
| Domain | Glyco_hydro_31 | 3.36e-03 | 7 | 242 | 2 | IPR000322 | |
| Domain | APC_su10/DOC_dom | 3.36e-03 | 7 | 242 | 2 | IPR004939 | |
| Domain | DOC | 3.36e-03 | 7 | 242 | 2 | PS51284 | |
| Domain | Glyco_hydro_31 | 3.36e-03 | 7 | 242 | 2 | PF01055 | |
| Domain | ANAPC10 | 3.36e-03 | 7 | 242 | 2 | PF03256 | |
| Pathway | KEGG_GALACTOSE_METABOLISM | 1.48e-05 | 26 | 175 | 5 | M4377 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.28e-05 | 76 | 175 | 7 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.81e-05 | 85 | 175 | 7 | M16441 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | LAMA1 COL6A5 ITGA2B ITGAD ITGAL ADAMTS9 COL14A1 COL4A2 COL12A1 VTN TGFB1 TLL2 MADCAM1 | 9.55e-05 | 300 | 175 | 13 | M610 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 HEXA TRPM4 EPPK1 MAN2A2 MYCBP2 SPEG PIEZO1 CUL9 EML2 BIRC6 NOD2 EHBP1L1 NBEAL2 PKD1 WDR90 HERC1 SCARA3 SEMA4F NSD2 ESYT1 TIMM23B KHNYN TWNK MAPKAPK5 EML3 KIFC2 SCAP MEGF8 MFSD5 | 4.32e-10 | 1105 | 248 | 30 | 35748872 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HEXA MAN2A2 MYCBP2 TNFSF9 TMEM165 PIEZO1 COPE LAMA1 LGR4 PTPRK SLC5A6 TMEM131L ANTXR1 SEC61A1 TAP1 SCARA3 ADGRA3 COL4A2 NPR1 COL12A1 WFS1 ESYT1 PLBD2 TGFB1 ERG28 SCAP P2RX5 MEGF8 LPL ADGRE5 MFSD5 | 7.29e-10 | 1201 | 248 | 31 | 35696571 |
| Pubmed | 2.53e-08 | 26 | 248 | 6 | 24742657 | ||
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 3.74e-08 | 6 | 248 | 4 | 22989508 | |
| Pubmed | 3.74e-08 | 6 | 248 | 4 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 3.74e-08 | 6 | 248 | 4 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 3.74e-08 | 6 | 248 | 4 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 3.74e-08 | 6 | 248 | 4 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 3.74e-08 | 6 | 248 | 4 | 8661406 | |
| Pubmed | 3.74e-08 | 6 | 248 | 4 | 23017337 | ||
| Pubmed | 3.74e-08 | 6 | 248 | 4 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 3.74e-08 | 6 | 248 | 4 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 3.74e-08 | 6 | 248 | 4 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 3.74e-08 | 6 | 248 | 4 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 3.74e-08 | 6 | 248 | 4 | 11709093 | |
| Pubmed | 3.74e-08 | 6 | 248 | 4 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 3.74e-08 | 6 | 248 | 4 | 23875777 | |
| Pubmed | 8.69e-08 | 7 | 248 | 4 | 22535526 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 8.69e-08 | 7 | 248 | 4 | 17504171 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 8.69e-08 | 7 | 248 | 4 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 8.69e-08 | 7 | 248 | 4 | 22640593 | |
| Pubmed | 8.69e-08 | 7 | 248 | 4 | 22465675 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 8.69e-08 | 7 | 248 | 4 | 9384381 | |
| Pubmed | 1.73e-07 | 8 | 248 | 4 | 20147394 | ||
| Pubmed | 1.73e-07 | 8 | 248 | 4 | 23260110 | ||
| Pubmed | 1.73e-07 | 8 | 248 | 4 | 8812145 | ||
| Pubmed | 1.73e-07 | 8 | 248 | 4 | 20096780 | ||
| Pubmed | 1.73e-07 | 8 | 248 | 4 | 14694110 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 3.09e-07 | 9 | 248 | 4 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 3.09e-07 | 9 | 248 | 4 | 8892894 | |
| Pubmed | 3.09e-07 | 9 | 248 | 4 | 18775311 | ||
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 3.58e-07 | 3 | 248 | 3 | 7780165 | |
| Pubmed | MON2 SPNS1 HK2 MYCBP2 TMEM165 COPE FCSK VPS52 RAB7A SEC61A1 VTN DYNC2H1 FPGS PLBD2 KIAA1671 DCAF10 PPM1F MAP2K7 | 4.39e-07 | 606 | 248 | 18 | 36538041 | |
| Pubmed | 5.12e-07 | 10 | 248 | 4 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 5.12e-07 | 10 | 248 | 4 | 1991513 | |
| Pubmed | 5.12e-07 | 10 | 248 | 4 | 23575248 | ||
| Pubmed | 5.12e-07 | 10 | 248 | 4 | 16805797 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | TRPM4 SPNS1 MAL KATNB1 MCL1 ADCY1 SPG21 SLC35A4 SLC5A6 APLNR PKD1 TAP1 ADGRA3 WFS1 MFSD4A ERG28 APH1A DCAF10 MFSD3 | 7.57e-07 | 697 | 248 | 19 | 28298427 |
| Pubmed | 8.01e-07 | 11 | 248 | 4 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 8.01e-07 | 11 | 248 | 4 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 8.01e-07 | 11 | 248 | 4 | 19639585 | |
| Pubmed | 1.19e-06 | 12 | 248 | 4 | 23071112 | ||
| Pubmed | Defining brain wiring patterns and mechanisms through gene trapping in mice. | 2.39e-06 | 14 | 248 | 4 | 11242070 | |
| Pubmed | 2.39e-06 | 14 | 248 | 4 | 21923909 | ||
| Pubmed | 2.39e-06 | 14 | 248 | 4 | 17411366 | ||
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 11698076 | ||
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 18509452 | ||
| Pubmed | APOBEC3 inhibits DEAD-END function to regulate microRNA activity. | 3.54e-06 | 5 | 248 | 3 | 23890083 | |
| Pubmed | 3.57e-06 | 33 | 248 | 5 | 19834762 | ||
| Pubmed | 5.58e-06 | 17 | 248 | 4 | 17360745 | ||
| Pubmed | 5.58e-06 | 17 | 248 | 4 | 8997639 | ||
| Pubmed | 6.56e-06 | 64 | 248 | 6 | 22261194 | ||
| Pubmed | 8.32e-06 | 186 | 248 | 9 | 20673868 | ||
| Pubmed | 8.32e-06 | 186 | 248 | 9 | 20452482 | ||
| Pubmed | HEXA MAN2A2 HK2 TIMM23 ACTL6A ITGA2B PFKL TMEM131L DPP7 COL4A2 PLBD2 TGFB1 MEGF8 PPM1F PRF1 MAP2K7 | 9.90e-06 | 613 | 248 | 16 | 22268729 | |
| Pubmed | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. | 1.23e-05 | 7 | 248 | 3 | 19118250 | |
| Pubmed | 1.23e-05 | 7 | 248 | 3 | 17035996 | ||
| Pubmed | 1.23e-05 | 7 | 248 | 3 | 30289203 | ||
| Pubmed | 1.53e-05 | 44 | 248 | 5 | 19322198 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 1.67e-05 | 22 | 248 | 4 | 16526095 | |
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 2.01e-05 | 23 | 248 | 4 | 22004035 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TRPM4 SPNS1 TNFSF9 LGR4 RAB7A HERC1 ADGRA3 SLC12A6 DYNC2H1 WFS1 FPGS SLC19A2 COTL1 TGFB1 CMIP SCAP APH1A ADGRE5 MFSD5 PRRC1 MFSD3 | 2.78e-05 | 1061 | 248 | 21 | 33845483 |
| Pubmed | 2.85e-05 | 167 | 248 | 8 | 22159717 | ||
| Pubmed | 2.92e-05 | 9 | 248 | 3 | 9827803 | ||
| Pubmed | Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis. | 2.92e-05 | 9 | 248 | 3 | 14742542 | |
| Pubmed | 2.92e-05 | 9 | 248 | 3 | 21074528 | ||
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 2.92e-05 | 9 | 248 | 3 | 12297046 | |
| Pubmed | SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth. | 3.89e-05 | 27 | 248 | 4 | 33227706 | |
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 4.14e-05 | 10 | 248 | 3 | 21749862 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 18092344 | ||
| Pubmed | Off-response property of an acid-activated cation channel complex PKD1L3-PKD2L1. | 5.06e-05 | 2 | 248 | 2 | 18535624 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 20538909 | ||
| Pubmed | Acetic acid activates PKD1L3-PKD2L1 channel--a candidate sour taste receptor. | 5.06e-05 | 2 | 248 | 2 | 19464260 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 21933102 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 37349598 | ||
| Pubmed | A novel PKD2L1 C-terminal domain critical for trimerization and channel function. | 5.06e-05 | 2 | 248 | 2 | 25820328 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 11124526 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 19003546 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 25905642 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 3023046 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 33852876 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 24026422 | ||
| Pubmed | Effect of ultrasound irradiation on α-SMA and TGF-β1 expression in human dermal fibroblasts. | 5.06e-05 | 2 | 248 | 2 | 21937873 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 38098265 | ||
| Pubmed | GDNF acts as a chemoattractant to support ephrinA-induced repulsion of limb motor axons. | 5.06e-05 | 2 | 248 | 2 | 21109439 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 35092565 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 33444400 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 7686151 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 22275377 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 33828560 | ||
| Pubmed | Abnormal corneal endothelial maturation in collagen XII and XIV null mice. | 5.06e-05 | 2 | 248 | 2 | 23599329 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 27194451 | ||
| Pubmed | alpha-Actin proteins and gene transcripts are colocalized in embryonic mouse muscle. | 5.06e-05 | 2 | 248 | 2 | 1893870 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 22253918 | ||
| Pubmed | Hormonal regulation of mitochondrial Tim23 gene expression in the mouse mammary gland. | 5.06e-05 | 2 | 248 | 2 | 11165051 | |
| Pubmed | Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability. | 5.06e-05 | 2 | 248 | 2 | 25888683 | |
| Pubmed | The single pore residue Asp523 in PKD2L1 determines Ca2+ permeation of the PKD1L3/PKD2L1 complex. | 5.06e-05 | 2 | 248 | 2 | 21185261 | |
| Pubmed | Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. | 5.06e-05 | 2 | 248 | 2 | 18424703 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 2731651 | ||
| Pubmed | A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA. | 5.06e-05 | 2 | 248 | 2 | 6897014 | |
| Interaction | POTEJ interactions | 1.67e-07 | 52 | 239 | 8 | int:POTEJ | |
| Interaction | WASH8P interactions | 5.96e-06 | 11 | 239 | 4 | int:WASH8P | |
| Interaction | YIPF3 interactions | PIEZO1 SLC5A6 APLNR RAB7A WFS1 MFSD11 SLC19A2 TP53I11 ADGRE5 LPAR2 MFSD5 | 1.43e-05 | 186 | 239 | 11 | int:YIPF3 |
| Cytoband | 2p13.1 | 3.39e-05 | 34 | 248 | 4 | 2p13.1 | |
| GeneFamily | Actins | 1.14e-07 | 6 | 171 | 4 | 929 | |
| GeneFamily | Solute carriers | SLC12A8 SLC35D1 SLC2A10 SLC41A2 SLC35A4 SLC5A6 SLC25A53 SLC49A3 SLC25A29 SLC25A17 SLC12A6 SLC19A2 SLCO6A1 SLC40A1 SLC28A2 SLC7A10 | 1.13e-06 | 395 | 171 | 16 | 752 |
| GeneFamily | WD repeat domain containing | KATNB1 EML2 NBEAL2 POC1B WDR90 HERC1 WDFY4 EML3 SCAP DCAF10 GNB5 | 4.10e-05 | 262 | 171 | 11 | 362 |
| GeneFamily | Fibronectin type III domain containing | 1.43e-04 | 160 | 171 | 8 | 555 | |
| GeneFamily | ATP binding cassette subfamily D | 5.27e-04 | 4 | 171 | 2 | 808 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 6.11e-04 | 18 | 171 | 3 | 1160 | |
| GeneFamily | Collagens | 9.25e-04 | 46 | 171 | 4 | 490 | |
| GeneFamily | Olfactory receptors, family 11 | 1.28e-03 | 23 | 171 | 3 | 159 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.06e-03 | 27 | 171 | 3 | 1253 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.06e-03 | 9 | 171 | 2 | 1230 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | SPNS1 MAN2A2 HK3 PIEZO1 COPE MBD1 KATNB1 IRF7 PFKL ITGAL SPG21 EHBP1L1 VPS52 TMEM131L ANKS1A TUT4 PILRB KHNYN WASHC1 COTL1 EML3 DNAH1 CLIP4 CMIP SCAP ADGRE5 MFSD3 | 1.12e-07 | 905 | 244 | 27 | M40865 |
| Coexpression | P53_DN.V1_DN | MAL TNFSF9 ACTA2 LAMA1 ITGAL ADCY1 PLA2G4A RAD51C SLC19A2 ARHGEF10 IL1R1 | 2.24e-06 | 194 | 244 | 11 | M2697 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | CYBB HEXA HK2 HK3 SPEG TMEM165 ACTBL2 LGR4 MCL1 ITGAD ITGAL F7 SLC2A10 SLC41A2 ANTXR1 PLA2G4A COL14A1 PIF1 DPP7 ANKFY1 VTN PILRB WFS1 SEMA5A WDFY4 APOBEC3B COTL1 LPL ADGRE5 | 5.34e-06 | 1242 | 244 | 29 | M1920 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | CYBB HEXA HK2 HK3 SPEG TMEM165 ACTBL2 LGR4 MCL1 ITGAD ITGAL F7 SLC2A10 SLC41A2 ANTXR1 PLA2G4A COL14A1 PIF1 DPP7 APOBEC3D ANKFY1 VTN PILRB WFS1 SEMA5A WDFY4 APOBEC3B COTL1 LPL ADGRE5 | 5.82e-06 | 1316 | 244 | 30 | MM1052 |
| Coexpression | FEVR_CTNNB1_TARGETS_UP | PDE7A ACTA1 MCL1 SLC12A8 IRF7 CD163 VPS52 PIM1 APLNR PKD1 RAB7A SEC61A1 TAP1 VTN WFS1 KHNYN COTL1 KIFC2 EDN3 | 2.69e-05 | 688 | 244 | 19 | M2342 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.70e-05 | 166 | 244 | 9 | M39026 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | CHST5 EPPK1 SPEG CUL9 PKDREJ EHBP1L1 SCARA3 SEMA4F KCP FADS6 EDN3 SPTBN4 P2RX5 LPL SLIT1 ADGRE5 SLC7A10 | 3.03e-05 | 574 | 244 | 17 | MM820 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | SPNS1 PIEZO1 PFKL ITGAL SPG21 VPS52 TMEM131L TUT4 PILRB KHNYN WASHC1 GK5 EML3 DNAH1 CLIP4 CMIP SCAP ADGRE5 | 3.07e-05 | 634 | 244 | 18 | M40866 |
| Coexpression | QI_HYPOXIA | 3.62e-05 | 133 | 244 | 8 | M2133 | |
| Coexpression | QI_HYPOXIA | 5.22e-05 | 140 | 244 | 8 | MM1290 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | EPPK1 SPEG CUL9 PKDREJ EHBP1L1 SCARA3 SEMA4F KCP FADS6 EDN3 SPTBN4 P2RX5 LPL SLIT1 ADGRE5 SLC7A10 | 5.64e-05 | 544 | 244 | 16 | M1936 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SPNS1 EPPK1 TNFSF9 PIEZO1 ACTL6A MEN1 SLC2A10 PTPRK SLC5A6 SEC61A1 ADGRA3 COL4A2 ESYT1 MFSD11 SLC19A2 TGFB1 ERG28 MFSD5 | 7.69e-05 | 681 | 244 | 18 | M5314 |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP | 1.01e-04 | 50 | 244 | 5 | M40985 | |
| Coexpression | GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP | 1.06e-04 | 198 | 244 | 9 | M6221 | |
| Coexpression | GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP | 1.06e-04 | 198 | 244 | 9 | M9244 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.09e-04 | 27 | 244 | 4 | M47994 | |
| Coexpression | ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN | 1.10e-04 | 116 | 244 | 7 | M2222 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN | 1.10e-04 | 199 | 244 | 9 | M8385 | |
| Coexpression | GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP | 1.10e-04 | 199 | 244 | 9 | M5687 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN | 1.14e-04 | 200 | 244 | 9 | M3394 | |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP | 1.14e-04 | 200 | 244 | 9 | M7234 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN | 1.14e-04 | 200 | 244 | 9 | M6270 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | ITGAL PKDREJ KCNQ3 ABCD2 EFCAB2 MAPKAPK5 TGFB1 ARHGEF10 SLC7A10 | 1.14e-04 | 200 | 244 | 9 | M6652 |
| Coexpression | HALLMARK_P53_PATHWAY | 1.14e-04 | 200 | 244 | 9 | M5939 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP | 1.14e-04 | 200 | 244 | 9 | M5241 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN | 1.14e-04 | 200 | 244 | 9 | M7807 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SPNS1 EPPK1 TNFSF9 PIEZO1 ACTL6A MEN1 SLC2A10 PTPRK SLC5A6 SEC61A1 ADGRA3 COL4A2 ESYT1 MFSD11 SLC19A2 TGFB1 ERG28 MFSD5 | 1.15e-04 | 703 | 244 | 18 | MM1055 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | ACTA1 ACTA2 ACTC1 ACTG2 RYR3 SLC2A10 EHBP1L1 COL14A1 COL12A1 ABCC9 LRRN4 | 7.38e-06 | 184 | 237 | 11 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 DSCAML1 FREM1 RYR3 PTPRQ SCN9A MGAM COL12A1 DNAH1 DGKK LRP2 ROS1 | 5.69e-10 | 184 | 248 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 DSCAML1 FREM1 RYR3 PTPRQ SCN9A MGAM COL12A1 DNAH1 DGKK LRP2 ROS1 | 5.69e-10 | 184 | 248 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 DSCAML1 FREM1 RYR3 PTPRQ SCN9A MGAM COL12A1 DNAH1 DGKK LRP2 ROS1 | 5.69e-10 | 184 | 248 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYCBP2 LAMA1 COL6A5 ADARB1 FREM1 PHEX COL14A1 SCARA3 DYNC2H1 SEMA5A SLC40A1 LPL | 1.39e-09 | 199 | 248 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SPEG TMEM165 ACTA2 ACTG2 RYR3 ADAMTS9 ANTXR1 SCARA3 COL4A2 CACNA1C IL1R1 | 7.91e-09 | 185 | 248 | 11 | e58a009aaf342be019a909747b1895d5987d4daf |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | MYCBP2 LAMA1 COL6A5 PTGER1 FREM1 PHEX COL14A1 COL4A2 DYNC2H1 LPL IL1R1 | 1.77e-08 | 200 | 248 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 COL6A5 DSCAML1 FREM1 RYR3 PTPRQ VWA3A COL12A1 KCP LRP2 | 2.38e-08 | 160 | 248 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 COL6A5 DSCAML1 FREM1 RYR3 PTPRQ VWA3A COL12A1 KCP LRP2 | 2.38e-08 | 160 | 248 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-08 | 175 | 248 | 10 | 1973fff0d7e1a94b31f461a39b91cc7984ebd8f1 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-08 | 176 | 248 | 10 | 1e430dffddd315d9a1cb4bd7fef5077656351c65 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.88e-08 | 176 | 248 | 10 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-08 | 182 | 248 | 10 | aab96e856bb4cb4418a97b7b1aa06505cafb317a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-08 | 183 | 248 | 10 | c12a4603cf81b5736553a4530cea5cefab80556f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-08 | 184 | 248 | 10 | 94139bc2c880db3a791741ff7c5630cca52263a5 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | RAB9B ACTA2 ACTC1 ACTG2 ADARB1 ADCY1 COL14A1 SCARA3 COL4A2 SLIT1 | 1.04e-07 | 187 | 248 | 10 | 35f25780d113f60bf4c13749013c09612ee4ff41 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ACTA2 ACTG2 ADAMTS9 ANTXR1 COL14A1 COL4A2 CACNA1C COL12A1 ABCC9 SEMA5A | 1.20e-07 | 190 | 248 | 10 | d6b3a92119b210974a32af3fe9875d60eb02761e |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | SPEG ACTA2 ACTG2 ADAMTS9 ANTXR1 COL14A1 COL4A2 CACNA1C COL12A1 SEMA5A | 1.27e-07 | 191 | 248 | 10 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 196 | 248 | 10 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 196 | 248 | 10 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG ACTA2 LAMA1 ACTG2 RYR3 ANTXR1 COL4A2 CACNA1C OVCH2 SEMA5A | 1.69e-07 | 197 | 248 | 10 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL6A5 PTGER1 FREM1 PHEX COL14A1 SCARA3 SEMA5A SLC40A1 LPL IL1R1 | 1.85e-07 | 199 | 248 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL6A5 PTGER1 FREM1 PHEX COL14A1 SCARA3 SEMA5A SLC40A1 LPL IL1R1 | 1.94e-07 | 200 | 248 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL6A5 PTGER1 FREM1 PHEX COL14A1 SCARA3 SEMA5A SLC40A1 LPL IL1R1 | 1.94e-07 | 200 | 248 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-07 | 153 | 248 | 9 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-07 | 165 | 248 | 9 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 169 | 248 | 9 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 169 | 248 | 9 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 169 | 248 | 9 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.74e-07 | 173 | 248 | 9 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 173 | 248 | 9 | 9ba55e21d1037ec3150d77895e52f0b051df65da | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | EPPK1 SPEG ACTA2 ACTG2 ADAMTS9 ANTXR1 COL14A1 COL4A2 CACNA1C | 7.63e-07 | 179 | 248 | 9 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-07 | 180 | 248 | 9 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-07 | 181 | 248 | 9 | a93df1ba23d5b5f249491d69d12bfc0e274dafcf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-07 | 181 | 248 | 9 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 9.18e-07 | 183 | 248 | 9 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | SPEG ACTA2 ACTG2 ANTXR1 COL14A1 COL4A2 CACNA1C COL12A1 SEMA5A | 1.10e-06 | 187 | 248 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ACTA2 ANTXR1 SCARA3 ADGRA3 COL4A2 CACNA1C COL12A1 IL1R1 DISP1 | 1.10e-06 | 187 | 248 | 9 | c104fbfef2d0bef64077ac721edf2379fd59d547 |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | SPEG ACTA2 ACTC1 ACTG2 ADAMTS9 ANTXR1 COL14A1 COL4A2 CACNA1C | 1.15e-06 | 188 | 248 | 9 | b66264e8f8d536ed2beec31e6746c687718f239b |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-06 | 188 | 248 | 9 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 PTGER1 ADARB1 FREM1 PHEX ANTXR1 COL14A1 CACNA1C SEMA5A | 1.20e-06 | 189 | 248 | 9 | a153b83314cf52808f685296cff8c95af3f4983d |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | ACTA2 ACTG2 ADAMTS9 ANTXR1 COL14A1 SCARA3 COL4A2 ABCC9 SEMA5A | 1.20e-06 | 189 | 248 | 9 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 PTGER1 ADARB1 FREM1 PHEX ANTXR1 COL14A1 CACNA1C SEMA5A | 1.25e-06 | 190 | 248 | 9 | 841cd55861b43578d704418b9bc0af2e8b88323a |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.25e-06 | 190 | 248 | 9 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-06 | 191 | 248 | 9 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | SPEG ACTA2 ACTC1 ADAMTS9 TMEM131L COL4A2 CACNA1C COL12A1 ABCC9 | 1.31e-06 | 191 | 248 | 9 | fad8eaa536001b911d05ae2b12150c2398cc6f88 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 142 | 248 | 8 | 6469cf82552b39f63e20b841c9eed50de6f58d54 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 192 | 248 | 9 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 ADARB1 FREM1 PHEX ANTXR1 COL14A1 SCARA3 CACNA1C SEMA5A | 1.37e-06 | 192 | 248 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 ADARB1 PHEX ANTXR1 COL14A1 SCARA3 COL4A2 CACNA1C SEMA5A | 1.37e-06 | 192 | 248 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 ADARB1 FREM1 PHEX ANTXR1 COL14A1 SCARA3 CACNA1C SEMA5A | 1.49e-06 | 194 | 248 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-06 | 195 | 248 | 9 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG ACTA2 ACTG2 ADAMTS9 COL14A1 COL4A2 CACNA1C PRSS56 COX6A2 | 1.69e-06 | 197 | 248 | 9 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-06 | 197 | 248 | 9 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-06 | 197 | 248 | 9 | 31bc9fd679d78550541d4158568e8dd09ff29e8e | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | ACTA2 ADAMTS9 ANTXR1 COL14A1 ADGRA3 COL4A2 CACNA1C COL12A1 IL1R1 | 1.84e-06 | 199 | 248 | 9 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG ACTA2 ACTC1 ACTG2 PTGER1 ADAMTS9 COL14A1 COL4A2 CACNA1C | 1.84e-06 | 199 | 248 | 9 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.84e-06 | 199 | 248 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG ACTA2 ACTG2 ANTXR1 COL14A1 COL4A2 CACNA1C COL12A1 SEMA5A | 1.84e-06 | 199 | 248 | 9 | 20f760d92c351a1dac4cc0a424c443ea03a179fe |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | SPEG ACTA2 ACTG2 ANTXR1 COL14A1 COL4A2 CACNA1C COL12A1 SEMA5A | 1.84e-06 | 199 | 248 | 9 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.92e-06 | 200 | 248 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADARB1 PTX3 ANTXR1 COL14A1 SCARA3 CACNA1C COL12A1 SLC40A1 IL1R1 | 1.92e-06 | 200 | 248 | 9 | a4ec0e80f5422b91b85264a9bb74568dd577e285 |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ACTA2 ACTG2 PTGER1 ADAMTS9 PTX3 COL14A1 COL4A2 CACNA1C ABCC9 | 1.92e-06 | 200 | 248 | 9 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.01e-06 | 158 | 248 | 8 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 3.15e-06 | 159 | 248 | 8 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Notum))|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.30e-06 | 73 | 248 | 6 | 50a8164d967f2706344adcdc1562dc08c9f16c8f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.46e-06 | 161 | 248 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.46e-06 | 161 | 248 | 8 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | facs-Heart-RA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 165 | 248 | 8 | 995f1524965a4314938f27165166f0aaff9dea02 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.53e-06 | 167 | 248 | 8 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 119 | 248 | 7 | 018162114bc22a9780fded5887f1f78211851700 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-06 | 169 | 248 | 8 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.63e-06 | 172 | 248 | 8 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.88e-06 | 173 | 248 | 8 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 173 | 248 | 8 | a37f38478473290fe35aea8684befc3bf95b161f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.88e-06 | 173 | 248 | 8 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.88e-06 | 173 | 248 | 8 | 7713716ec95932b2fac177ce4cfec027b4754cef | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-06 | 174 | 248 | 8 | b487c5c46f074a69b9526a2c72daf218f66aa44b | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-06 | 174 | 248 | 8 | 3533a47885af453d97739e5576e989d93d31be32 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.13e-06 | 174 | 248 | 8 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-06 | 174 | 248 | 8 | dc4298c1d9359f7e37454e9451f889017227d5cf | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 175 | 248 | 8 | 92a4a3fd323ee8360edd659f9e16dfddc8788e2f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.95e-06 | 177 | 248 | 8 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.95e-06 | 177 | 248 | 8 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.25e-06 | 178 | 248 | 8 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | COPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class | 7.55e-06 | 179 | 248 | 8 | 5c705627bd13a5b2c7b0062fb3d94e4eb1589327 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.86e-06 | 180 | 248 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-06 | 181 | 248 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-06 | 181 | 248 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.53e-06 | 182 | 248 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 8.87e-06 | 183 | 248 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 8.87e-06 | 183 | 248 | 8 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-06 | 183 | 248 | 8 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.87e-06 | 183 | 248 | 8 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.61e-06 | 185 | 248 | 8 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.61e-06 | 185 | 248 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.61e-06 | 185 | 248 | 8 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 9.99e-06 | 186 | 248 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.99e-06 | 186 | 248 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 9.99e-06 | 186 | 248 | 8 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-05 | 187 | 248 | 8 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| Drug | AC1L1ERT | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ITGA2B SLC2A10 BTN1A1 PRF1 | 3.25e-09 | 69 | 244 | 10 | CID000002920 |
| Drug | Nsc687160 | 2.37e-08 | 18 | 244 | 6 | CID005459290 | |
| Drug | tolytoxin | 3.44e-08 | 19 | 244 | 6 | CID006440827 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 6.26e-08 | 34 | 244 | 7 | CID000001312 | |
| Drug | NSC312786 | 6.76e-08 | 21 | 244 | 6 | CID000329495 | |
| Drug | AC1L8NVR | 6.76e-08 | 21 | 244 | 6 | CID000384633 | |
| Drug | manidipine | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A RYR3 PKD1 CACNA1C PKD1L3 | 7.57e-08 | 95 | 244 | 10 | CID000004008 |
| Drug | prostacyclin sodium salt | ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ITGA2B PTGER1 ADCY1 PLA2G4A COL14A1 NPR1 COL12A1 ADAMTS13 EDN3 LPL | 9.15e-08 | 250 | 244 | 15 | CID000000159 |
| Drug | sodium | TRPM4 SPNS1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SLC12A8 ACTL6A ADCY1 RYR3 PHEX SLC2A10 SLC5A6 PKD1 SCN9A TAP1 SLC12A6 CACNA1C MGAM NPR1 COX6A2 SLC19A2 PLBD2 EDN3 USP10 PRF1 SLC28A2 LRP2 SLC7A10 | 1.10e-07 | 944 | 244 | 30 | CID000000923 |
| Drug | losartan | CYBB ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ITGA2B ITGAD ITGAL SLC2A10 COL14A1 NPR1 COL12A1 EDN3 CARD8 TGFB1 LPL | 1.56e-07 | 378 | 244 | 18 | CID000003961 |
| Drug | epsilon-ATP | 2.46e-07 | 41 | 244 | 7 | CID000162262 | |
| Drug | azaspiracid | 6.82e-07 | 30 | 244 | 6 | CID006451158 | |
| Drug | arabinosyladenine | HK2 HK3 GANC ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ITGA2B PFKL ADARB1 F7 ADCY1 RYR3 PHEX PKD1 CACNA1C MGAM NPR1 ABCC9 PKD1L3 RHO P2RX5 SLC28A2 | 7.66e-07 | 762 | 244 | 25 | CID000000191 |
| Drug | caged ATP | 8.26e-07 | 70 | 244 | 8 | CID000123806 | |
| Drug | CaCl2 | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ADCY1 SLC25A29 MGAM NPR1 LPAR2 | 1.02e-06 | 156 | 244 | 11 | CID000024854 |
| Drug | AC1L1HS4 | 1.02e-06 | 32 | 244 | 6 | CID000004267 | |
| Drug | m2-19 | 1.40e-06 | 19 | 244 | 5 | CID000079129 | |
| Drug | N,N'-p-phenylenedimaleimide | 1.49e-06 | 34 | 244 | 6 | CID000076765 | |
| Drug | amiloride | TRPM4 ACTBL2 ACTC1 ACTL6A PKDREJ RYR3 PKD1 SCN9A CACNA1C MGAM SLC19A2 TMEM14C PKD2L1 PKD1L3 USP10 | 1.73e-06 | 315 | 244 | 15 | CID000016230 |
| Drug | GTP[S] | COPE ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A PTGER1 ADCY1 RYR3 PKD1 SCN9A PLA2G4A CACNA1C MGAM NPR1 PKD1L3 KIFC2 RHO LPL GNB5 | 1.78e-06 | 591 | 244 | 21 | CID000001764 |
| Drug | AC1NSKFN | 2.12e-06 | 36 | 244 | 6 | CID005311324 | |
| Drug | AC1L1BDQ | TRPM4 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ADCY1 NOD2 TGFB1 LPL | 2.80e-06 | 173 | 244 | 11 | CID000001394 |
| Drug | dihydrocytochalasin B | 2.81e-06 | 58 | 244 | 7 | CID000003064 | |
| Drug | 0-to | ACTBL2 ACTA1 ACTA2 BAK1 ACTC1 ACTG2 ACTL6A PTGER1 PLA2G4A LPAR2 | 3.01e-06 | 141 | 244 | 10 | CID000002051 |
| Drug | LMWH | HEXA ACTA1 ACTA2 LAMA1 ACTC1 ACTG2 ACTL6A ITGA2B F7 ADCY1 RYR3 PTX3 KCNQ3 FGF6 COL14A1 COL12A1 VTN ADAMTS13 TGFB1 LPL LRP2 EPHA4 | 3.04e-06 | 663 | 244 | 22 | CID000000772 |
| Drug | D-myo-inositol-1,4,5-triphosphate | TRPM4 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A PTGER1 ADCY1 RYR3 PKD1 PLA2G4A CACNA1C NPR1 PKD1L3 YES1 EDN3 RHO LPL SLC7A10 | 3.62e-06 | 568 | 244 | 20 | CID000000806 |
| Drug | candesartan cilexetil | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A COL14A1 TAP1 COL12A1 TGFB1 | 3.87e-06 | 145 | 244 | 10 | CID000002540 |
| Drug | colchine | ACTBL2 ACTA1 ACTA2 LAMA1 ACTC1 ACTG2 ACTL6A PTX3 PKD1 FGF6 COL14A1 DPP7 COL12A1 TGFB1 LPL LRP2 | 4.23e-06 | 383 | 244 | 16 | CID000002833 |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | TMEM165 PIEZO1 LGR4 FAXDC2 NBEAL2 SLC25A17 INHBE TWNK RET ERN2 EML3 | 6.56e-06 | 189 | 244 | 11 | 1168_DN |
| Drug | AC1L8FNU | 7.15e-06 | 44 | 244 | 6 | CID000425429 | |
| Drug | gallopamil | 7.50e-06 | 67 | 244 | 7 | CID000001234 | |
| Drug | mitiglinide | 9.03e-06 | 27 | 244 | 5 | CID000121891 | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | ACTA1 ACTC1 PHEX FGF6 SEMA4F NPR1 TP53I11 EFCAB2 SEMA5A RET MADCAM1 | 1.02e-05 | 198 | 244 | 11 | 3814_UP |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | MBD1 ACTA2 EML2 ITGA2B ADCY1 ZNF589 SCN9A GPR19 ERN2 CARD8 TSPAN1 | 1.07e-05 | 199 | 244 | 11 | 1811_UP |
| Drug | taxol | ACTBL2 ACTA1 ACTA2 LAMA1 BAK1 ACTC1 ACTG2 MCL1 ACTL6A ITGAL PKDREJ BIRC6 SPG21 PKD1 TWNK RET PKD1L3 SLC40A1 TGFB1 | 1.08e-05 | 560 | 244 | 19 | CID000004666 |
| Drug | CID5288653 | 1.09e-05 | 28 | 244 | 5 | CID005288653 | |
| Drug | NpCaM | 1.20e-05 | 48 | 244 | 6 | CID000122259 | |
| Drug | AC1Q6LQU | 1.20e-05 | 48 | 244 | 6 | CID000072380 | |
| Drug | U46619 | ACTBL2 ACTC1 ACTL6A ITGA2B PTGER1 ADCY1 RYR3 PKD1 CACNA1C NPR1 PKD1L3 EDN3 TGFB1 | 1.36e-05 | 285 | 244 | 13 | CID000005618 |
| Drug | manganese | HEXA ACTA1 ACTA2 LAMA1 ACTC1 ACTG2 ACTL6A ITGA2B ITGAD ITGAL F7 ADCY1 RYR3 PKD1 ANTXR1 TAP1 CACNA1C MGAM NPR1 VTN PKD1L3 LPL MADCAM1 | 1.55e-05 | 791 | 244 | 23 | CID000023930 |
| Drug | AC1L1KMJ | ACTBL2 ACTA1 ACTA2 LAMA1 ACTC1 ACTG2 ACTL6A ITGA2B PIM1 PKD1 ANTXR1 COL14A1 COL12A1 VTN TGFB1 SPTBN4 PRF1 | 1.65e-05 | 476 | 244 | 17 | CID000030956 |
| Drug | phorbol acetate myristate | CYBB ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 MCL1 ACTL6A ITGA2B ITGAD ITGAL PTGER1 ADCY1 CD163 RYR3 EHBP1L1 CD163L1 PKD1 PLA2G4A CACNA1C INHBE NPR1 VTN RET PKD1L3 YES1 APOBEC3B EDN3 TGFB1 LPL SLC28A2 ADGRE5 IL1R1 | 1.72e-05 | 1399 | 244 | 33 | CID000004792 |
| Drug | SIRIUS | 1.89e-05 | 77 | 244 | 7 | CID000091750 | |
| Drug | celgosivir | 2.12e-05 | 16 | 244 | 4 | CID000060734 | |
| Drug | AC1NQAAM | 2.61e-05 | 144 | 244 | 9 | CID005192834 | |
| Drug | Y-27632 | CYBB ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A PTGER1 MEN1 SCN9A COL14A1 CACNA1C COL12A1 EDN3 TGFB1 LPAR2 | 2.64e-05 | 444 | 244 | 16 | CID000005711 |
| Drug | 3-methylhistidine | 2.66e-05 | 55 | 244 | 6 | CID000064969 | |
| Drug | genistein | TNFSF9 ACTBL2 ACTA1 ACTA2 LAMA1 ACTC1 ACTG2 IRF7 ACTL6A ITGA2B ITGAD ITGAL RYR3 PTPRK PKD1 PLA2G4A SEC61A1 RAD51C CACNA1C PILRB TP53I11 RET PKD1L3 YES1 APOBEC3B TGFB1 LPL LPAR2 | 2.74e-05 | 1117 | 244 | 28 | CID005280961 |
| Drug | plakin | 2.86e-05 | 82 | 244 | 7 | CID000018752 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ADCY1 RYR3 PKD1 SLC12A6 CACNA1C NPR1 PKD1L3 EDN3 | 3.06e-05 | 308 | 244 | 13 | CID000001915 |
| Drug | Aspidium | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ST7L EHBP1L1 BTN1A1 RHO | 3.12e-05 | 184 | 244 | 10 | CID000000815 |
| Drug | Bay K 8644 | 3.60e-05 | 150 | 244 | 9 | CID000002303 | |
| Drug | nitric oxide | CYBB HEXA NEIL2 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ITGA2B ITGAD ITGAL PTGER1 F7 ADCY1 RYR3 NOD2 APLNR SLC12A6 INHBE NPR1 COX6A2 YES1 EDN3 TGFB1 IL1R1 SLC7A10 | 3.72e-05 | 1075 | 244 | 27 | CID000145068 |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | ACTBL2 ACTA1 ACTA2 LAMA1 ACTC1 ACTG2 ACTL6A ITGAL ADCY1 PLA2G4A EDN3 TGFB1 LPL | 3.73e-05 | 314 | 244 | 13 | CID000003542 |
| Drug | fasudil | 3.79e-05 | 151 | 244 | 9 | CID000003547 | |
| Drug | Pb m | 4.12e-05 | 118 | 244 | 8 | CID006327255 | |
| Drug | mag-indo-1 | 4.12e-05 | 7 | 244 | 3 | CID000131881 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A | MAL ACTA2 ACTC1 ACTG2 FAXDC2 KCNQ3 NPR1 TP53I11 SEMA5A ADAMTS13 | 4.28e-05 | 191 | 244 | 10 | 3291_UP |
| Drug | Rp-cAMPS | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A PTGER1 ADCY1 CACNA1C NPR1 | 4.89e-05 | 194 | 244 | 10 | CID006426631 |
| Drug | prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | MAN2A2 KATNB1 PEX11A EHBP1L1 PIM1 SLC12A6 GPR19 TP53I11 ERN2 TSPAN1 | 5.10e-05 | 195 | 244 | 10 | 6552_DN |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | TNFSF9 PEX11A TARBP1 SLC25A17 DYNC2H1 FPGS ERN2 TSPAN1 PPM1F LRP2 | 5.33e-05 | 196 | 244 | 10 | 5523_DN |
| Drug | chlorpromazine | 5.56e-05 | 197 | 244 | 10 | CID000002726 | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 5.56e-05 | 197 | 244 | 10 | 6514_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; HL60; HT_HG-U133A | FAXDC2 ADARB1 ZNF589 COL4A2 RET ERN2 PPM1F LPAR2 MAP2K7 EPHA4 | 5.56e-05 | 197 | 244 | 10 | 2205_DN |
| Drug | AC1L22RD | 5.61e-05 | 91 | 244 | 7 | CID000065183 | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; PC3; HT_HG-U133A | KATNB1 ACTG2 SLC35D1 NBEAL2 NSD2 KHNYN EML3 CARD8 ERG28 DCAF10 | 5.80e-05 | 198 | 244 | 10 | 7275_DN |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | TRPM4 KATNB1 ITGAL PIM1 FGF6 SCARA3 TP53I11 ERG28 ARHGEF10 MAP2K7 | 5.80e-05 | 198 | 244 | 10 | 7473_UP |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | LGR4 PEX11A SLC35D1 PHEX NBEAL2 SLC25A17 GPR19 COX6A2 ERN2 GNB5 | 5.80e-05 | 198 | 244 | 10 | 2651_DN |
| Drug | oryzalin | 5.81e-05 | 63 | 244 | 6 | CID000029393 | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | CHST5 EPPK1 SLC12A8 PEX11A EHBP1L1 TUT4 DYNC2H1 ERN2 ARHGEF10 ADGRE5 | 6.05e-05 | 199 | 244 | 10 | 5219_UP |
| Drug | Quercetine dihydrate [6151-25-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | FAXDC2 FGF6 COL14A1 NPR1 TP53I11 EFCAB2 EDN3 RHO MAP2K7 MADCAM1 | 6.31e-05 | 200 | 244 | 10 | 4264_UP |
| Drug | mDia | 6.45e-05 | 93 | 244 | 7 | CID000128346 | |
| Drug | AC1L3USJ | 6.67e-05 | 21 | 244 | 4 | CID000122544 | |
| Drug | Mgamp-pnp | 6.67e-05 | 21 | 244 | 4 | CID005311323 | |
| Drug | methyl ethyl ketone | ACTA1 ACTA2 LAMA1 BAK1 ACTC1 ACTG2 MCL1 ACTL6A ITGA2B PLA2G4A VTN RET YES1 MAPKAPK5 TGFB1 LPL LPAR2 EPHA4 | 6.87e-05 | 587 | 244 | 18 | CID000006569 |
| Drug | NSC618487 | ACTBL2 ACTA1 ACTA2 BAK1 ACTC1 ACTG2 MCL1 ACTL6A ITGA2B ITGAL PTGER1 ADCY1 PLA2G4A SEC61A1 SLC12A6 CACNA1C INHBE NPR1 YES1 EDN3 TGFB1 LPL IL1R1 EPHA4 | 7.12e-05 | 933 | 244 | 24 | CID000005279 |
| Drug | 5-IAF | 7.56e-05 | 66 | 244 | 6 | CID000123822 | |
| Drug | AC1OAGFB | TRPM4 SPNS1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ADCY1 SCN9A PLA2G4A KCNQ3 HERC1 EDN3 RHO SPTBN4 LPL | 7.79e-05 | 539 | 244 | 17 | CID006857345 |
| Drug | AC1L1KC5 | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A RYR3 PKD1 PLA2G4A SCARA3 CACNA1C NPR1 WFS1 PKD1L3 ERN2 EDN3 SCAP | 8.15e-05 | 541 | 244 | 17 | CID000005428 |
| Drug | NSC613009 | 8.19e-05 | 130 | 244 | 8 | CID000003800 | |
| Drug | KT5926 | 8.35e-05 | 42 | 244 | 5 | CID000122126 | |
| Drug | verapamil | BIRC6 ADCY1 RYR3 PKD1 SCN9A ABCD4 KCNQ3 ABCD2 TAP1 CACNA1C MGAM ABCB6 ABCC9 PKD1L3 EDN3 TGFB1 | 8.48e-05 | 490 | 244 | 16 | CID000002520 |
| Drug | phloretin | 8.64e-05 | 131 | 244 | 8 | CID000004788 | |
| Drug | nitrendipine | 9.00e-05 | 98 | 244 | 7 | CID000004507 | |
| Drug | bumetanide | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SLC12A8 ACTL6A SLC5A6 SLC12A6 NPR1 | 9.10e-05 | 209 | 244 | 10 | CID000002471 |
| Drug | N-nonyl-deoxygalactonojirimycin | 9.71e-05 | 23 | 244 | 4 | CID000501390 | |
| Drug | AC1L2AC7 | 9.71e-05 | 69 | 244 | 6 | CID000068733 | |
| Drug | khellin | 9.93e-05 | 171 | 244 | 9 | CID000003828 | |
| Drug | AC1MNW2N | 1.05e-04 | 70 | 244 | 6 | CID003359490 | |
| Drug | Betamethasone-d5 | TNFSF9 ACTBL2 ACTA1 ACTA2 CYP20A1 LAMA1 ACTC1 ACTG2 MCL1 IRF7 ACTL6A ITGA2B ITGAD ITGAL PTGER1 ADCY1 CD163 SLC2A10 PTX3 SCN9A PLA2G4A ANXA9 INHBE EDN3 TGFB1 PBRM1 PRF1 LPL ACIN1 IL1R1 | 1.10e-04 | 1340 | 244 | 30 | CID000003003 |
| Drug | tesaglitazar | PDE7A SPEG IRF7 PFKL PEX11A NOD2 ANTXR1 SLC25A29 ABCD2 INHBE FMO1 COL12A1 TMEM14C PPM1F LRP2 IL1R1 | 1.12e-04 | 502 | 244 | 16 | ctd:C501413 |
| Drug | AC1Q5THZ | CYBB HEXA ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ITGA2B ADCY1 PLA2G4A MGAM NPR1 VTN EDN3 LPL | 1.12e-04 | 502 | 244 | 16 | CID000001959 |
| Drug | lanthanum | 1.12e-04 | 136 | 244 | 8 | CID000023926 | |
| Drug | alpha-bisabolene | 1.14e-04 | 2 | 244 | 2 | CID000086597 | |
| Drug | AC1L1IZ2 | TRPM4 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ADCY1 RYR3 PIM1 MGAM NPR1 | 1.17e-04 | 304 | 244 | 12 | CID000004795 |
| Drug | AC1NRBPQ | 1.18e-04 | 137 | 244 | 8 | CID005288569 | |
| Drug | beryllium fluoride | 1.23e-04 | 103 | 244 | 7 | CID000024589 | |
| Drug | NSC107658 | HK2 HK3 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ITGA2B ITGAL SLC2A10 SLC19A2 | 1.24e-04 | 306 | 244 | 12 | CID000002919 |
| Drug | CAS 298-57-7 | 1.33e-04 | 73 | 244 | 6 | CID000002761 | |
| Drug | NaCl | ACTBL2 ACTA1 ACTA2 LAMA1 ACTC1 ACTG2 SLC12A8 ACTL6A PFKL ADCY1 SLC25A29 MGAM NPR1 PKD2L1 EDN3 TGFB1 LPL | 1.34e-04 | 564 | 244 | 17 | CID000005234 |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.69e-09 | 8 | 235 | 5 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.69e-09 | 8 | 235 | 5 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.69e-09 | 8 | 235 | 5 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.69e-09 | 8 | 235 | 5 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 7.49e-09 | 10 | 235 | 5 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 7.49e-09 | 10 | 235 | 5 | DOID:13832 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | DAO PFKL ADARB1 NOD2 PLA2G4A KCNQ3 SLC12A6 CACNA1C WFS1 TGFB1 PBRM1 ARHGEF10 TLL2 | 1.30e-04 | 477 | 235 | 13 | C0005586 |
| Disease | Liver Cirrhosis, Experimental | CYBB TMEM165 ACTA2 DAO ITGA2B ITGAL CD163 PLA2G4A DPP7 COL4A2 INHBE FMO1 COL12A1 SLC19A2 COTL1 TGFB1 LPL | 1.72e-04 | 774 | 235 | 17 | C0023893 |
| Disease | Colorectal Carcinoma | HK3 LAMA1 EML2 DSCAML1 ABCD4 ACTL9 ABCD2 FPGS ABCB6 RET TGFB1 PPM1F GNB5 LRP2 ACIN1 IGSF21 | 1.77e-04 | 702 | 235 | 16 | C0009402 |
| Disease | Multiple Endocrine Neoplasia | 1.88e-04 | 3 | 235 | 2 | C0027662 | |
| Disease | blood molybdenum measurement | 2.34e-04 | 38 | 235 | 4 | EFO_0007582 | |
| Disease | hyperglycemia (implicated_via_orthology) | 3.12e-04 | 17 | 235 | 3 | DOID:4195 (implicated_via_orthology) | |
| Disease | end stage renal disease (biomarker_via_orthology) | 5.35e-04 | 47 | 235 | 4 | DOID:783 (biomarker_via_orthology) | |
| Disease | CCHS WITH HIRSCHSPRUNG DISEASE | 6.22e-04 | 5 | 235 | 2 | C1859049 | |
| Disease | kallikrein-7 measurement | 6.22e-04 | 5 | 235 | 2 | EFO_0008195 | |
| Disease | Congenital absence of kidneys syndrome | 6.22e-04 | 5 | 235 | 2 | C1609433 | |
| Disease | low-density lipoprotein receptor-related protein 1, soluble measurement | 6.22e-04 | 5 | 235 | 2 | EFO_0801772 | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 6.22e-04 | 5 | 235 | 2 | DOID:13317 (implicated_via_orthology) | |
| Disease | sex interaction measurement, bilirubin measurement | 6.87e-04 | 22 | 235 | 3 | EFO_0004570, EFO_0008343 | |
| Disease | Kidney Diseases | 7.03e-04 | 88 | 235 | 5 | C0022658 | |
| Disease | Brugada Syndrome (disorder) | 8.92e-04 | 24 | 235 | 3 | C1142166 | |
| Disease | Aganglionic megacolon | 9.28e-04 | 6 | 235 | 2 | cv:C0019569 | |
| Disease | Curling Ulcer | 9.28e-04 | 6 | 235 | 2 | C0010474 | |
| Disease | Duodenal Ulcer | 9.28e-04 | 6 | 235 | 2 | C0013295 | |
| Disease | Hypertrophic Cardiomyopathy | 1.11e-03 | 57 | 235 | 4 | C0007194 | |
| Disease | Depressive Symptoms | 1.13e-03 | 26 | 235 | 3 | C0086132 | |
| Disease | eye measurement | 1.27e-03 | 27 | 235 | 3 | EFO_0004731 | |
| Disease | dipeptidyl peptidase 2 measurement | 1.29e-03 | 7 | 235 | 2 | EFO_0020326 | |
| Disease | Congenital central hypoventilation | 1.29e-03 | 7 | 235 | 2 | C1275808 | |
| Disease | Psychotic Disorders | 1.31e-03 | 101 | 235 | 5 | C0033975 | |
| Disease | Breast Carcinoma | MAL ACTA2 SLC2A10 PIM1 PLA2G4A RAD51C DYNC2H1 NSD2 APOBEC3B COTL1 PBRM1 MAP2K7 | 1.36e-03 | 538 | 235 | 12 | C0678222 |
| Disease | Cerebral Hemorrhage | 1.41e-03 | 28 | 235 | 3 | C2937358 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.62e-03 | 63 | 235 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | Unilateral agenesis of kidney | 1.71e-03 | 8 | 235 | 2 | C0266294 | |
| Disease | HLA allele carrier status | 1.71e-03 | 8 | 235 | 2 | EFO_0803322 | |
| Disease | Colorectal Neoplasms | 1.79e-03 | 277 | 235 | 8 | C0009404 | |
| Disease | coronary artery disease, factor VII measurement | 1.98e-03 | 111 | 235 | 5 | EFO_0001645, EFO_0004619 | |
| Disease | diabetes mellitus | 2.14e-03 | 68 | 235 | 4 | EFO_0000400 | |
| Disease | factor VIII measurement, coronary artery disease | 2.15e-03 | 113 | 235 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | pulmonary sarcoidosis (is_implicated_in) | 2.19e-03 | 9 | 235 | 2 | DOID:13406 (is_implicated_in) | |
| Disease | margarate 17:0 measurement | 2.19e-03 | 9 | 235 | 2 | EFO_0021066 | |
| Disease | Nonorganic psychosis | 2.26e-03 | 69 | 235 | 4 | C0349204 | |
| Disease | joint hypermobility measurement | 2.28e-03 | 33 | 235 | 3 | EFO_0007905 | |
| Disease | factor XI measurement, coronary artery disease | 2.32e-03 | 115 | 235 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.51e-03 | 71 | 235 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.59e-03 | 118 | 235 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | Inflammatory Bowel Diseases | 2.70e-03 | 35 | 235 | 3 | C0021390 | |
| Disease | Asthma, Occupational | 2.72e-03 | 10 | 235 | 2 | C0264423 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 2.72e-03 | 10 | 235 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | Pleural Diseases | 2.72e-03 | 10 | 235 | 2 | C0032226 | |
| Disease | creatinine measurement | PDE7A SPEG ACTG2 BIRC6 SLC35D1 TMEM131L FGF6 SLC25A29 ANXA9 COL4A2 FBXL17 PKD1L3 USP10 LPL SLC28A2 LRP2 IGSF21 | 2.73e-03 | 995 | 235 | 17 | EFO_0004518 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.93e-03 | 36 | 235 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Hirschsprung's disease (is_implicated_in) | 3.31e-03 | 11 | 235 | 2 | DOID:10487 (is_implicated_in) | |
| Disease | Shortened QT interval | 3.31e-03 | 11 | 235 | 2 | C0151879 | |
| Disease | Occupational Diseases | 3.31e-03 | 11 | 235 | 2 | C0028797 | |
| Disease | Nephrosclerosis | 3.31e-03 | 11 | 235 | 2 | C0027719 | |
| Disease | Copper-Overload Cirrhosis | 3.31e-03 | 11 | 235 | 2 | C1876165 | |
| Disease | Ashkenazi Jewish disorders | 3.31e-03 | 11 | 235 | 2 | cv:CN118946 | |
| Disease | angina pectoris | 3.32e-03 | 125 | 235 | 5 | EFO_0003913 | |
| Disease | Mammary Carcinoma, Human | MAL ACTA2 SLC2A10 PIM1 PLA2G4A RAD51C DYNC2H1 NSD2 APOBEC3B COTL1 MAP2K7 | 3.44e-03 | 525 | 235 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | MAL ACTA2 SLC2A10 PIM1 PLA2G4A RAD51C DYNC2H1 NSD2 APOBEC3B COTL1 MAP2K7 | 3.44e-03 | 525 | 235 | 11 | C1257931 |
| Disease | Lung diseases | 3.53e-03 | 78 | 235 | 4 | C0024115 | |
| Disease | Mammary Neoplasms | MAL ACTA2 SLC2A10 PIM1 PLA2G4A RAD51C DYNC2H1 NSD2 APOBEC3B COTL1 MAP2K7 | 3.54e-03 | 527 | 235 | 11 | C1458155 |
| Disease | thioredoxin domain-containing protein 12 measurement | 3.69e-03 | 39 | 235 | 3 | EFO_0008298 | |
| Disease | Carcinoma, Neuroendocrine | 3.95e-03 | 12 | 235 | 2 | C0206695 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 3.95e-03 | 12 | 235 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia (implicated_via_orthology) | 3.95e-03 | 12 | 235 | 2 | DOID:1168 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 3.97e-03 | 40 | 235 | 3 | C0598589 | |
| Disease | Hypertensive disease | 4.29e-03 | 190 | 235 | 6 | C0020538 | |
| Disease | plasma beta-amyloid 1-42 measurement | 4.65e-03 | 13 | 235 | 2 | EFO_0005660 | |
| Disease | aplastic anemia (is_implicated_in) | 4.65e-03 | 13 | 235 | 2 | DOID:12449 (is_implicated_in) | |
| Disease | smoking status measurement, ulcerative colitis | 4.65e-03 | 13 | 235 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 4.65e-03 | 13 | 235 | 2 | C1846647 | |
| Disease | sphingomyelin 18:1 measurement | 4.65e-03 | 13 | 235 | 2 | EFO_0010394 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 4.80e-03 | 85 | 235 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | fibroblast growth factor 23 measurement | 4.87e-03 | 43 | 235 | 3 | EFO_0009381 | |
| Disease | non-high density lipoprotein cholesterol measurement | ATAT1 CD163 CD163L1 POC1B ANXA9 SLC25A17 COL4A2 VTN GK5 CMIP PBRM1 LPL SLC7A10 | 4.96e-03 | 713 | 235 | 13 | EFO_0005689 |
| Disease | Schizophrenia | LAMA1 DAO ADARB1 CD163 PLA2G4A KCNQ3 TAP1 NPAS1 CACNA1C TGFB1 PBRM1 LPL LRP2 MAP2K7 SLC7A10 | 5.02e-03 | 883 | 235 | 15 | C0036341 |
| Disease | Autistic Disorder | 5.11e-03 | 261 | 235 | 7 | C0004352 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 5.40e-03 | 14 | 235 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | thyroid peroxidase antibody measurement, anti-thyroglobulin antibody measurement | 5.53e-03 | 45 | 235 | 3 | EFO_0005666, EFO_0009896 | |
| Disease | Malignant neoplasm of breast | MAL HK3 ACTA2 PKDREJ SLC2A10 PIM1 PLA2G4A RAD51C INHBE DYNC2H1 NSD2 ABCB6 APOBEC3B COTL1 PBRM1 PPM1F MAP2K7 | 5.81e-03 | 1074 | 235 | 17 | C0006142 |
| Disease | Aganglionosis, Colonic | 6.19e-03 | 15 | 235 | 2 | C0085758 | |
| Disease | Aganglionosis, Rectosigmoid Colon | 6.19e-03 | 15 | 235 | 2 | C1257840 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 6.19e-03 | 15 | 235 | 2 | C3645536 | |
| Disease | BMI-adjusted adiponectin measurement | 6.19e-03 | 15 | 235 | 2 | EFO_0007737 | |
| Disease | Osteopenia | 6.19e-03 | 15 | 235 | 2 | C0029453 | |
| Disease | triacylglycerol 52:3 measurement | 6.19e-03 | 15 | 235 | 2 | EFO_0010415 | |
| Disease | Carcinoma of Endocrine Gland | 6.19e-03 | 15 | 235 | 2 | C1704374 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 6.25e-03 | 47 | 235 | 3 | DOID:9074 (is_marker_for) | |
| Disease | severe acute respiratory syndrome (is_marker_for) | 6.25e-03 | 47 | 235 | 3 | DOID:2945 (is_marker_for) | |
| Disease | Hereditary hearing loss and deafness | 6.39e-03 | 146 | 235 | 5 | cv:C0236038 | |
| Disease | adiponectin measurement | 6.39e-03 | 146 | 235 | 5 | EFO_0004502 | |
| Disease | Cardiomyopathy, Dilated | 6.63e-03 | 48 | 235 | 3 | C0007193 | |
| Disease | resting heart rate | 6.95e-03 | 149 | 235 | 5 | EFO_0004351 | |
| Disease | phosphorus measurement | 7.04e-03 | 16 | 235 | 2 | EFO_0004861 | |
| Disease | Dermatitis | 7.04e-03 | 16 | 235 | 2 | C0011603 | |
| Disease | Myocardial Infarction | 7.09e-03 | 95 | 235 | 4 | C0027051 | |
| Disease | Adenocarcinoma of large intestine | 7.36e-03 | 96 | 235 | 4 | C1319315 | |
| Disease | Fibrosis | 7.42e-03 | 50 | 235 | 3 | C0016059 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLGRTGTLVEEAFWI | 1031 | Q9UKV3 | |
| LDRWFTLSSGQGQVL | 891 | Q9BSJ8 | |
| GIWIAFTSGSTLRLF | 1121 | O15013 | |
| ILSGGSLFNWIVSII | 3081 | Q96N23 | |
| FSVQEQLATGGILWF | 201 | Q8N8Q8 | |
| IKRGRSNLLWDTGVF | 41 | Q96AK3 | |
| RRALGIGFQWLSLAT | 6 | Q9H6X2 | |
| LLVGTDFNRGDISWG | 2386 | Q9NR09 | |
| LAALRGNSLWVQSSG | 131 | A4D250 | |
| GLELWQVRSGTIFDN | 301 | Q96L12 | |
| IKRGRSNLLWDTGVF | 41 | Q9UH17 | |
| GGWRFEQLDTAIRLT | 681 | Q9UBJ2 | |
| VLGLLTIGSIFFTWR | 256 | Q13410 | |
| TSLFESGINWGRVVA | 116 | Q16611 | |
| LEHSGSVGLALFVWV | 66 | Q9NS82 | |
| VWIGGSILASLSTFQ | 341 | P68133 | |
| RLRVFGTGQKDWTAT | 176 | Q8N6M5 | |
| WIGGSILASLSTFQQ | 341 | Q562R1 | |
| LLGTDSTGNVRTGLW | 1301 | Q8IWK6 | |
| FVLLQFTTGRWTLGS | 121 | Q15760 | |
| NTLLDSRGWGTLLSR | 46 | P10767 | |
| TVERRFSSWIGGSIL | 386 | O96019 | |
| VVRVFQGQGLSTRWL | 641 | P48960 | |
| VWIGGSILASLSTFQ | 341 | P62736 | |
| RNFSVWIGGSILASL | 376 | Q8TC94 | |
| WIGGSILASLRAFQS | 381 | Q8TC94 | |
| LNLWSTQFGDAGLRL | 691 | Q8IY22 | |
| WLLLGTVTVGFLAQS | 16 | P08572 | |
| GSTGFVSNLRTFLWI | 321 | Q9NP58 | |
| WIGGSILASLSTFQQ | 341 | P63267 | |
| LTQLATAWVSLATGG | 181 | O14579 | |
| WGSGLATLSNIDIRI | 681 | O60706 | |
| ISGLRTLEQSVGEWL | 691 | Q92625 | |
| LRVLGGLWTSTRGSV | 431 | O14678 | |
| WTVRTVLGSSENALG | 76 | P16066 | |
| LRDASFGQGTGTIWL | 1296 | Q9NR16 | |
| TDFASGIWLGLELRS | 646 | Q8N3C7 | |
| AFVFRGGRWTTESQL | 131 | A6NI87 | |
| FVTVGSLVLLGWELN | 1021 | Q96F81 | |
| GASLEWSQARGLLFS | 1156 | Q76LX8 | |
| LGESWGHAATIRLIF | 301 | O43502 | |
| GLRVWQFVSAVLFSG | 61 | O14683 | |
| IWDTAGQERFQSLGV | 61 | P51149 | |
| VDGRFVTLQIWDTAG | 51 | Q9NP90 | |
| VWDVLKGSRVSILFG | 351 | O14775 | |
| FATLGGEIALWSLVV | 116 | P08100 | |
| LQRAGGFVWLQSVAT | 371 | Q99742 | |
| VTLGGIFQLGNWSEL | 236 | P14920 | |
| WATFLVQSLGRFEGQ | 441 | O00255 | |
| LGTTGNGLVLWTVFR | 41 | P35414 | |
| DSRDQTVLGLALWTG | 586 | Q9P2R3 | |
| GSVSWVLSLIDAFGL | 551 | Q5KSL6 | |
| LSLGISQATGSAARW | 86 | Q5VUJ9 | |
| ALTITGNGAIAFVLW | 51 | Q8NH07 | |
| FGELSRLVGTEWRNL | 1406 | Q86U86 | |
| ASVQWRGLDTSLGAV | 56 | Q13477 | |
| LLRDTLQSFSWNGRG | 431 | Q8IW41 | |
| LEGQAGSVQRASLIW | 786 | Q9BY89 | |
| LSLEGWFLRQGLLDT | 96 | Q9HBW0 | |
| LRVSFGLFGSVWVND | 131 | Q969S2 | |
| GGVFKRTLAQSLWAL | 71 | Q8N468 | |
| FLDLIGTIGLSWTFL | 466 | O95528 | |
| WFRNTSGLTRLQLDG | 126 | A6NM62 | |
| LWAFITAGGSLRSIQ | 226 | Q96BI3 | |
| ASLTAVLLGGWILFV | 436 | Q76MJ5 | |
| TGTIIWDSQLLGFTF | 1101 | O43451 | |
| STGTIIWDSQLLGFT | 1996 | O43451 | |
| TWEGRLIAATFSLIG | 326 | O43525 | |
| GLLATSGNDGTIRVW | 3441 | Q15751 | |
| ELIVAGSQSGSIRVW | 76 | Q9BVA0 | |
| VTLLDSRSVQGELGW | 31 | P54764 | |
| LALDLGGTNFRVLWV | 81 | P52789 | |
| VLLWALVRAQGTGSV | 11 | P58166 | |
| IFSLGGTRFRDTAVW | 576 | Q9UIS9 | |
| IIRDEGISALWNGTF | 156 | O43808 | |
| LAVWLQSLTASRGGV | 11 | P06858 | |
| WSLGISLVELATGQF | 306 | O14733 | |
| SLTGANIFRSEWGSL | 121 | P17858 | |
| LFFGGQELRTSTVWD | 441 | P14222 | |
| WSVRLDFGDVLLATG | 461 | P14222 | |
| LVALAVGGWSSTSLQ | 316 | P34995 | |
| WRSAVGLLRESGLFS | 286 | Q13946 | |
| QLFTTELGRAGIRWE | 291 | Q96G04 | |
| RLLVTSGFDGNVIIW | 266 | Q5QP82 | |
| LKWTVNGDTRVGLFA | 1151 | O96028 | |
| NGLQARTFGIWTLLS | 46 | Q9UKR5 | |
| GLSLLEGQSRAITWE | 421 | Q5H8C1 | |
| LGRTIGIFWLNASET | 276 | Q8TET4 | |
| WQGALLSTAQGAISR | 541 | Q8N3D4 | |
| GVRITNFTTSWRNGL | 1056 | Q8N3D4 | |
| GLTAGGVTRDFWVLN | 1586 | Q7Z7M0 | |
| SIGVLELWVLATNFR | 101 | P62502 | |
| SQWELALRFVVGSFG | 1266 | P50748 | |
| TGILTFLDAVSWGRF | 591 | Q9BXB1 | |
| GTADGIAFDWITRRI | 2466 | P98164 | |
| TAAWGTLGTLRTFLN | 26 | O76027 | |
| RVLFGEWLLGEISSG | 11 | Q92985 | |
| GVNTLWGSFEISNVR | 436 | Q96RR1 | |
| ASGGADTQVLLWRTN | 286 | Q8TC44 | |
| GAVLGTSWQLVLATL | 691 | Q7Z3U7 | |
| ERLQGSDLFWRGVGS | 1121 | Q76FK4 | |
| QTWVREFILLGLSSD | 6 | O95006 | |
| SIGRNSGIFWALLQS | 131 | O43934 | |
| ARWNVVGIQGSLLSI | 561 | P78563 | |
| LGATGASLRVLWVTL | 96 | P52790 | |
| ARAWVTRSTAGLGLV | 66 | Q96ES6 | |
| LLQEVASTRGTGAWG | 151 | Q8TE96 | |
| GERVGSAGILLSWNT | 106 | Q9UMZ3 | |
| TLKGNLSFGWVRETL | 1041 | Q13349 | |
| NTAAWGGQLELRALS | 221 | Q8N6M0 | |
| AFTLVGRLDSWERQG | 436 | Q8N0W3 | |
| RIFSTILGNWLDGLL | 2376 | Q9P2D7 | |
| ILTSVFQGDWGSDIL | 2551 | Q8NCM8 | |
| RNGQESTLWIGSLGA | 156 | Q96EW2 | |
| LGSGLLSFVAFWNSV | 31 | Q96IV6 | |
| FWSFNGLLLVVDTTG | 91 | Q96IV6 | |
| WRTLGANALLFVGVN | 211 | Q08828 | |
| TGLSLTESARWISQG | 1881 | Q9P2N4 | |
| ISTENGILVTQGRRW | 3061 | Q9C0G6 | |
| FTWTRVGSRLLDGSA | 376 | Q96ID5 | |
| TTLGGQWLERSFATF | 316 | Q9P2D3 | |
| SFTWQVTLEGRAGAL | 601 | Q9P2D3 | |
| GEGIRTLLWTFIKSF | 1391 | Q13936 | |
| FALITWIGENVSGLQ | 76 | Q14019 | |
| LVFLVDGSWSVGRNN | 141 | Q99715 | |
| VLLVDGSWSIGRANF | 1201 | Q99715 | |
| WLLFGLTVTSAAGFV | 6 | P14138 | |
| GGAGARTWRLLTFVL | 21 | Q02221 | |
| RWTQRFDGNSIITGF | 906 | Q8TD84 | |
| ILVDGSWSIGRFNFR | 161 | Q05707 | |
| AWEQQGRSLFLASLG | 151 | Q9UF56 | |
| QLNGEATIGRALLWT | 2051 | A8TX70 | |
| FLSTTGGGWVISRIF | 211 | Q01740 | |
| LWSATGLGFLVRDEV | 191 | Q9Y2G2 | |
| LTWGFGVATVIDDRS | 661 | Q8IZF7 | |
| AEGWRVFTRGLASTL | 241 | Q8N8R3 | |
| FIFGGLVWILVASSL | 31 | P21145 | |
| QVWFSGLTGLLKSIR | 771 | P49641 | |
| VFWGLIALIGTSRGS | 6 | Q86SG7 | |
| SWTVGGDILNARFIR | 396 | Q5SQI0 | |
| FSIHIRIVGDWTEGL | 351 | P04839 | |
| FSGLIWVVLTLDGRD | 301 | Q8IYX4 | |
| GITTQVAARRGLSAW | 21 | Q05932 | |
| GLGISTQRATFITWN | 91 | Q6ZS86 | |
| LASWEGRSSALLGAQ | 206 | O15037 | |
| LSFGSSWLEGAVLEQ | 1606 | Q8IWT3 | |
| SVLAVGTVTGRWLLL | 431 | O95834 | |
| SLGGKDASIFQWRVL | 856 | Q32P44 | |
| FWFGRRLVVSLGTVD | 71 | Q6UW02 | |
| SGRLEVRFQGEWGTI | 276 | Q86VB7 | |
| LRLTWVVGTAGVLQA | 206 | Q9UHW9 | |
| VVLFLRTGWLVGNTG | 56 | A0AV02 | |
| GQILVSVAGWSLFSL | 176 | O60779 | |
| WSLELQGNLIVVGRS | 971 | Q12770 | |
| QVRGWQATTAGLDLS | 191 | Q6AZY7 | |
| IIILVRETSGFSWLG | 451 | P14778 | |
| LTSFWGGDLRAASNI | 396 | Q9UHL4 | |
| SEARGQVSWALGALS | 366 | Q96AC6 | |
| FGLVASSLVDWLGRK | 91 | Q6N075 | |
| WENALVFASGITILG | 76 | Q8N9I5 | |
| YTNVVGLGDSSTWRL | 146 | Q8N9I5 | |
| LSGTFLERVESGWIR | 211 | Q8WUT4 | |
| DGVTNWGRIVTLISF | 256 | Q07820 | |
| TRSLDVWIGFSTVQG | 461 | P98161 | |
| WRVNGTLAVSRAIGD | 316 | P49593 | |
| DLGSKTLTGLFRAWV | 511 | P0CW18 | |
| TLTGLFRAWVRAGLG | 516 | P0CW18 | |
| QFVAGWTLLGSDLFL | 206 | Q8NGH5 | |
| VTGFTGRDWLRAELA | 141 | Q15262 | |
| ALTITGNGAIAFVLW | 51 | Q8NG94 | |
| ALTITGNGAIAFVLW | 51 | B2RN74 | |
| TLAFSGRLTGFNIWD | 326 | P26022 | |
| GRLTGFNIWDSVLSN | 331 | P26022 | |
| GVWGSAFSILFNRVL | 391 | P47712 | |
| IFRLGSVIRWAGSDF | 231 | Q93086 | |
| TVWGALRGLETFSQL | 131 | P06865 | |
| VSSGFSGVIRLLDWF | 96 | P11309 | |
| ADRWTVQATGGQLLS | 526 | Q9H611 | |
| WAVFLASRSLGQGLL | 6 | Q96DX4 | |
| DLGGRKTLQQRWTTF | 276 | O95754 | |
| WRLTVFFVSLSLLGV | 871 | A2VDJ0 | |
| QITTISSFVGAWLGA | 156 | Q07326 | |
| VTGFDLWLSVLALGI | 171 | Q9Y289 | |
| RTLAFVRFSLVSGWG | 331 | P08709 | |
| VRFSLVSGWGQLLDR | 336 | P08709 | |
| RSGVAWTQEVAVLLG | 1261 | Q6ZWJ8 | |
| WGRLTEGGVLSQVLQ | 181 | Q7RTZ1 | |
| QLSARGGRLSLTWSV | 116 | Q9NTG1 | |
| VAFLWDLGSGSTRLE | 2176 | P25391 | |
| LTNVLFSVTWRGVEG | 1446 | Q6ZNJ1 | |
| WRERGQVFSVLTQLG | 1466 | Q6ZNJ1 | |
| GALQGQSVSVWELLF | 2981 | P58107 | |
| GALQGQSVSVWELLF | 4046 | P58107 | |
| GLDVFLLTTWTSLGN | 791 | Q7Z443 | |
| LFQITTSAGWDGLLA | 1691 | Q15858 | |
| VIWFVASSFLIGLGS | 171 | Q86UG4 | |
| FFTGRLTDWILQDGS | 206 | Q03518 | |
| GVIAARIGLWSFDLT | 461 | Q9NP59 | |
| GGFVDWTLRLNTIQS | 21 | Q96JW4 | |
| LVGRTWQSRTVLESG | 966 | Q6ZUB1 | |
| ATWIGASGDQTFLRI | 1051 | O75592 | |
| NLRWSGLLVTVGEVL | 386 | Q96M27 | |
| TILWVRSVGLTSGIN | 101 | O75192 | |
| RGGSLVILRSSVTWG | 271 | Q5H9E4 | |
| RQGLGASVVSWSDVI | 121 | P08514 | |
| GTQVLSGIQWFGRSI | 571 | P20701 | |
| WTNFIGLNISIAGSL | 311 | Q9NTN3 | |
| ADVFFRQILALTGWG | 56 | Q9NZD8 | |
| AVSWRTVFSGLGLQF | 196 | O43868 | |
| NDIGGRFLLEDTWTT | 256 | Q13591 | |
| VWIGGSILASLSTFQ | 341 | P68032 | |
| WTARGVQRAFEGTTL | 271 | Q9BWW9 | |
| LVLSSWRSGSSFLGQ | 66 | Q9GZS9 | |
| ASWDGGISRTVQFLV | 506 | Q9NQ89 | |
| DQLFSDLLGGTQRLW | 46 | Q495D7 | |
| RAATILGAWLNFAGS | 96 | Q6UXD7 | |
| NVWVFLATSGTLAGI | 61 | Q9P0S9 | |
| ARVTQLIRGFGSSWK | 636 | Q8N1B4 | |
| GTVTFWLLQQRGADI | 1271 | Q96KV7 | |
| DTILEVWLRGNTFSL | 1011 | Q9HC29 | |
| VLGSDQWTALVTGLR | 1326 | Q15772 | |
| RFSGNLLVSLLGTWS | 311 | P61619 | |
| TILGGIFQILWSTVF | 4201 | Q15413 | |
| GIAFWSLVTLGSSFI | 131 | Q9H2V7 | |
| WFERTTGILTSEGLA | 116 | Q5T4T6 | |
| QWLSRGGEIEGFRLS | 206 | P01137 | |
| GWATLLESIRQAGGI | 361 | A8K0Z3 | |
| AETSGETIQGFWLLT | 86 | Q6ZUI0 | |
| QSSGVWGNLISSLVF | 146 | Q86WB7 | |
| ARIQEQLFGELGLWS | 2261 | Q6ZS81 | |
| LITGGASQAVTLWDL | 221 | A0A1W2PR48 | |
| LWVEFRSSSNILGKG | 441 | Q9Y6L7 | |
| WLEFSRVIQGTTTLL | 386 | P78562 | |
| LEGFSGWAALVVLSQ | 246 | Q96G79 | |
| DSVLRQWALLTGLVG | 511 | Q9H254 | |
| GTSSLISGLIFIFEW | 86 | Q8TDW4 | |
| FWINGFRIITTQEIG | 896 | P08922 | |
| GRIQLTTELGFWTVS | 266 | O75678 | |
| FWTVSLRDGGRLSAT | 276 | O75678 | |
| LTLTFLAEWGDRSQL | 241 | Q9HC07 | |
| TRQGALWANTLGSLA | 121 | Q5SRD1 | |
| AWLTARGFQVTGLQS | 476 | Q6ZUG5 | |
| RLFLNWTEGQESGFL | 96 | Q9UKJ0 | |
| WTEGQESGFLRISNL | 101 | Q9UKJ0 | |
| GIRGLWGTTLTENTA | 76 | Q9P0L9 | |
| FSWLLRVLNDGISLG | 16 | Q9UFV1 | |
| WQLTQGATVLGLFRV | 226 | P41273 | |
| SFGVLLWEIVTLGGN | 936 | P07949 | |
| TTDVFQIGLNGWLRI | 751 | Q14694 | |
| NAIRETGWAFLELGT | 91 | Q8NHP8 | |
| VTAQIEGSSGALWRI | 2266 | Q92508 | |
| WRTVQAGLGQADALT | 266 | Q13395 | |
| GQWLRSSGLLFATFL | 171 | Q96GR4 | |
| WTSLQTIAGVLSGFL | 291 | Q6UX68 | |
| WSTNERGALVGFSSL | 156 | Q86UQ0 | |
| ISSWGGNRILEIQLS | 176 | Q86UQ0 | |
| SAAFRLWQILNGTGF | 1296 | O75093 | |
| NTESLGELWLGLLRF | 1181 | Q5TAX3 | |
| IFELLFWGRTSAGTR | 316 | P04004 | |
| SGGWATLLESIRQAG | 341 | Q9NQA3 | |
| QGILIFSQSWAVDLG | 416 | Q08AF3 | |
| TRQGALWANTLGSLA | 121 | O14925 | |
| GLVRAAQSTGAWIVT | 141 | Q8TD43 | |
| LQWLLSGSRRLFGTV | 941 | A6NCI4 | |
| LAVGIWVSIDGASFL | 26 | O60635 | |
| GLALVGVLQFARWFT | 576 | O76024 | |
| WSFGILQTELVTKGR | 456 | P07947 |